Monograph Tablets -0478- - European Pharmacopoeia -ph. Eur.-

Ph. Eur. Monograph 0478 provides a robust framework for ensuring the quality, safety, and efficacy of tablet formulations. By defining strict standards for identity, content uniformity, disintegration, and dissolution, the monograph ensures that patients receive a consistent dose of medication that performs reliably in the body. It remains a dynamic document, updated periodically to reflect advances in pharmaceutical technology and analytical science.

Ph. Eur. 0478 covers solid preparations each containing a single dose of one or more active substances. While it primarily addresses oral tablets, it excludes certain forms like lozenges or oral pastes, which have their own specific standards. Key Quality & Performance Tests

The European Pharmacopoeia does not exist in isolation. To reduce redundancy and facilitate global drug development, the Ph. Eur. works closely with the and the Japanese Pharmacopoeia (JP) through the Pharmacopoeial Discussion Group (PDG) and the ICH Q4B process. This collaboration aims to harmonize key general chapters.

Mandatory for most solid dosage forms to confirm the active substance is released as intended. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: Formulations meant to be dissolved or smoothly dispersed in water prior to ingestion.

: This test determines whether tablets break down within a specified time when placed in a liquid medium, ensuring the drug will be available for absorption. Subdivision of Tablets (Break-marks)

: Designed for slow release and localized action within the oral cavity or absorption across the oral mucosa. These cross-reference with Ph. Eur. Monograph Oromucosal Preparations (1807) . 3. Production and Manufacturing Standards the Ph. Eur.

Formulated to alter the rate or place of drug release; requirements are typically specified in individual monographs.

According to Monograph 0478, tablets are solid preparations each containing a single dose of one or more active substances. They are typically obtained by compressing uniform volumes of particles and may include excipients such as:

Her team met weekly with formulation scientists and quality-control analysts. Today’s agenda: a proposed update to the disintegration test in 0478. The change was technical but consequential — a small reduction in permitted disintegration time for chewable tablets intended for pediatric use. The lab’s dissolution profiles showed many current formulations would pass, but a few marginal products might fail. The meeting began with silence, then a measured exchange of data and risk assessments. which have their own specific standards.

[Granulation / Blending] ──> [In-Process Mechanical Testing] ──> [Microbiological & Divisibility Quality Checks]

The "Production" section of the monograph provides crucial requirements for the manufacturing process itself, focusing on critical quality attributes from the start.